Back
Blue Owl Capital Vs. Viking Therapeutics Industry Stock Comparison
Buy
57
OWL
Blue Owl Capital
Last Price:
22.84
Seasonality Move:
1.04%
Sell
28
VKTX
Viking Therapeutics
Last Price:
38.24
Seasonality Move:
40.87%
Buy
57
Blue Owl Capital (OWL)
is a Buy
Is Blue Owl Capital a Buy, Sell or Hold?
- The current Blue Owl Capital [OWL] share price is $22.84. The Score for OWL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- OWL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $38.28. The Score for VKTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OWL Stock Price Chart
What is Blue Owl Capital's stock price today?
-
The Blue Owl Capital share price today is $22.84
The current trend is moderately bearish and OWL is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $38.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
OWL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.32 | Buy |
Relative Strength Index (14 RSI): | 44 | Sell |
Chaikin Money Flow: | -6308356 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.97 - 24.37) | Sell |
Bollinger Bands (100): | (17.69 - 23.33) | Buy |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.91 | Sell |
Relative Strength Index (14 RSI): | 23.24 | Sell |
Chaikin Money Flow: | -10764092 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.91 - 53.55) | Sell |
Bollinger Bands (100): | (52.21 - 67.17) | Sell |
OWL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.06 | Sell |
20-day SMA: | 23.88 | Sell |
50-day SMA: | 23.1 | Sell |
200-day SMA: | 19.4 | Buy |
8-day EMA: | 23.92 | Sell |
20-day EMA: | 23.73 | Sell |
50-day EMA: | 22.77 | Buy |
200-day EMA: | 19.57 | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.82 | Sell |
20-day SMA: | 49.84 | Sell |
50-day SMA: | 58.67 | Sell |
200-day SMA: | 62.24 | Sell |
8-day EMA: | 46.02 | Sell |
20-day EMA: | 49.86 | Sell |
50-day EMA: | 55.23 | Sell |
200-day EMA: | 54.61 | Sell |
Blue Owl Capital Earnings Growth & OWL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.15 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.
Blue Owl Capital Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |